MARATTO

article · Scientific Reports

Evaluation of the antimicrobial and antioxidants potentialities of two Lebanese cultivars of Quinoa (Chenopodium Quinoa Willd.)

2025Open accessAlexandria University

Abstract

Quinoa is a historical food crop that has provided vital sustenance to communities for thousands of years, and its consumption has lately expanded due to its potent antioxidant properties and noteworthy antibacterial activities. The present research investigation was carried out to assess the antibacterial properties of two varieties of quinoa as well as their antioxidant activities. The ethanolic extract of both cultivars (Q12 and Taticaca) displayed moderate inhibition potentials that fall within the range of recognized broad-spectrum antibiotics against S. epidermidis, S. aureus, and E. coli. The quinoa extracts were found to have minimum inhibitory (MIC) and bactericidal (MBC) doses ranging from 375 to 750 µg/mL. The synergistic effects of quinoa extracts and antibiotics were also explored, revealing moderate synergistic interactions. The strains' ultrastructure revealed abnormalities related to the protoplasm and cell wall following treatment with quinoa extracts. These antibacterial and antioxidant activities, as documented in this study, can provide insight into how the two Lebanese cultivars of Quinoa might be used for further hygiene and food product preservation applications.

Research topics

  • Seed and Plant Biochemistry
  • Consumer Attitudes and Food Labeling
  • Heavy Metals in Plants

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1038/s41598-025-19992-7

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.